A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Cancer Genetics Education Program Bookmark and Share

Cancer Genetics Education Program

The Division of Clinical Cancer Genetics at City of Hope offers educational coursesand self-teaching tools forprofessionals in the fields of cancer and cancer genetics.ThisCancer Genetics Education Program (CGEP) is supported inpart by funding fromthe NCI (IRC4CA153828-01 andIR25CA112486).
 
Dramatic advances in our understanding of the genetic basis for cancer have led to the development of new technologies and tools for genetic cancer risk assessment. The Cancer Genetics Education Program at City of Hope offers a series of comprehensive learning tools designed to enhance the education of primary care physicians and clinical oncology professionals on the topics of cancer genetics and cancer risk assessment, and their application to patient care. Through a series of educational courses, workshops, seminars, newsletters and a direct, interactive electronic communications network, professionals can be tutored in the latest information on cancer molecular genetics, the fundamentals of obtaining an adequate family history, understanding genetic cancer risk assessment, ethical and legal complexities of genetic testing, and other current/timely topics.
 
Cancer Genetics Career Development Program
City of Hope offers an innovative  Cancer Genetics Career Development Program (CGCDP) whichprovides interdisciplinary training focused on cancer genetics and cancer prevention control research. The Traineeship is open to three applicants per year.
 
Intensive Course in Cancer Risk Assessment
City of Hope's Division of Clinical Cancer Genetics offers an annual CME/CEU-accredited multi-modal intensive course to address the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians.
 
Clinical Cancer Genetics Community of Practice
City of Hope CCG Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.

Clinical Cancer Genetics Community Research Network (CCGCRN)

The Clinical Cancer Genetics Community Research Network (CCGCRN) is a large research group of over 40 collaborating sites in the United States, Mexico, and South America. The cornerstone of this network is the City of Hope Hereditary Cancer Research Registry (Molecular Genetic Studies in Cancer Patients and their Relatives; IRB# 96144), a prospective research registry protocol initiated at the City of Hope in 1996, by Principal Investigator Jeffrey Weitzel, MD. The registry serves as a biospecimen repository with personal and family medical history, psycho-social and clinical follow-up data, and 4-generation family pedigree. As members of the CCGCRN, research collaborators can use the message board and forums to post questions and communicate with other members in the network.
 
 
City of Hope CCGCRN Objectives
 
  • To create common and complimentary community-based, locally relevant cancer genomics/genetics research agendas, especially among underserved outreach clinics
  • To address geographic, socioeconomic, and ethnic disparities in cancer genetics healthcare and research participation
  • To leverage next-generation genomic technologies to engage/promote hereditary cancer research and clinical translation globally, with a focus in Latin America
 
General questions or comments may be submitted via email to: ccgcrn@coh.org
 
 
General links of interest:
 
Links for members:

Working Group

Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team. CSPPN and affiliated clinicians across the U.S. present cases from their community practices via web conferencing for discussion and recommendations on risk assessment, surveillance, risk management and identification of research eligibility for cases covering the full spectrum of hereditary cancer.

2015 Clinical Cancer Genomics Update Conference

 
"From Evidence to Action: Next-Generation Approaches to Cancer Risk Assessment and Research"
City of Hope Division of Clinical Cancer Genetics (CCG), in collaboration with the University of Chicago, is excited to announce our 4th annual CME/CEU-accredited clinical cancer genetics and genomics update conference. The two-day conference will be held on Friday and Saturday, February 27 and 28, 2015, at City of Hope, Cooper Auditorium, in Duarte, CA.
 
 
 
 
Register earely and save!
 
        Conference Fee Structure*         
CCGCoP**
members:
Non-CCGCoP
members:
Physicians $200 $275
Genetic Counselors $100 $175
Nurses & other Health Professionals (NP, PA, SW) $100 $175
Industry $200 $275
Resident/Fellow $75 $125

*After 12/28/14, all fees will increase by $50.
**Affiliation with City of Hope Division of Clinical Cancer Genetics CCGCoP & CCGCRN
 
  • Prices include breakfast and lunch on Friday and Saturday, and a fun-filled networking dinner on Friday evening!
 
  • A block of rooms has been secured at a rate of $132 for single occupancy and $66 for shared at the Courtyard by Marriott, Monrovia, February 26 to 28, 2015. Don’t miss out on this great rate! (Conference attendees who want to extend their stay at the hotel may contact Karen Gadsby, at  626-531-8008.)
 
 
 
(group code pending)
 
To share accommodations with another conference attendee, contact Gloria Nunez at gnunez@coh.org no later than January 31, 2015.
 
 

Clinical Cancer Genetics Events Calendar

Cancer Genetics Education Program

Cancer Genetics Education Program

The Division of Clinical Cancer Genetics at City of Hope offers educational coursesand self-teaching tools forprofessionals in the fields of cancer and cancer genetics.ThisCancer Genetics Education Program (CGEP) is supported inpart by funding fromthe NCI (IRC4CA153828-01 andIR25CA112486).
 
Dramatic advances in our understanding of the genetic basis for cancer have led to the development of new technologies and tools for genetic cancer risk assessment. The Cancer Genetics Education Program at City of Hope offers a series of comprehensive learning tools designed to enhance the education of primary care physicians and clinical oncology professionals on the topics of cancer genetics and cancer risk assessment, and their application to patient care. Through a series of educational courses, workshops, seminars, newsletters and a direct, interactive electronic communications network, professionals can be tutored in the latest information on cancer molecular genetics, the fundamentals of obtaining an adequate family history, understanding genetic cancer risk assessment, ethical and legal complexities of genetic testing, and other current/timely topics.
 
Cancer Genetics Career Development Program
City of Hope offers an innovative  Cancer Genetics Career Development Program (CGCDP) whichprovides interdisciplinary training focused on cancer genetics and cancer prevention control research. The Traineeship is open to three applicants per year.
 
Intensive Course in Cancer Risk Assessment
City of Hope's Division of Clinical Cancer Genetics offers an annual CME/CEU-accredited multi-modal intensive course to address the need for professional training in clinical cancer genetics and research collaboration for community-based clinicians.
 
Clinical Cancer Genetics Community of Practice
City of Hope CCG Community of Practice brings cancer genetics practitioners from diverse practice settings together for professional learning, enduring patient-centered support and dynamic community-based research collaborations to promote quality care and improved patient outcomes across the U.S. and internationally.

CCGCRN

Clinical Cancer Genetics Community Research Network (CCGCRN)

The Clinical Cancer Genetics Community Research Network (CCGCRN) is a large research group of over 40 collaborating sites in the United States, Mexico, and South America. The cornerstone of this network is the City of Hope Hereditary Cancer Research Registry (Molecular Genetic Studies in Cancer Patients and their Relatives; IRB# 96144), a prospective research registry protocol initiated at the City of Hope in 1996, by Principal Investigator Jeffrey Weitzel, MD. The registry serves as a biospecimen repository with personal and family medical history, psycho-social and clinical follow-up data, and 4-generation family pedigree. As members of the CCGCRN, research collaborators can use the message board and forums to post questions and communicate with other members in the network.
 
 
City of Hope CCGCRN Objectives
 
  • To create common and complimentary community-based, locally relevant cancer genomics/genetics research agendas, especially among underserved outreach clinics
  • To address geographic, socioeconomic, and ethnic disparities in cancer genetics healthcare and research participation
  • To leverage next-generation genomic technologies to engage/promote hereditary cancer research and clinical translation globally, with a focus in Latin America
 
General questions or comments may be submitted via email to: ccgcrn@coh.org
 
 
General links of interest:
 
Links for members:

Working Group

Working Group

Clinical Cancer Genetics (CCG) Working Group is a CME-accredited interdisciplinary cancer genetics case conference series conducted each week by the City of Hope clinical team. CSPPN and affiliated clinicians across the U.S. present cases from their community practices via web conferencing for discussion and recommendations on risk assessment, surveillance, risk management and identification of research eligibility for cases covering the full spectrum of hereditary cancer.

Cancer Genetics Community Link

Cancer Genetics Community Link Discussion Board

The Cancer Genetics Community Discussion Board is a Web-based discussion board for collaborative, interdisciplinary practice-based support and continuing professional learning. CCG Community of Practice members are encouraged to post and respond to case-based questions and share resources with a growing, multidisciplinary network of professionals engaged in the practice of clinical cancer genetics. Messages are posted and archived under topic-specific forums, allowing members to search for information by topic of interest.
 
Case Consultation Questions

Breast/Ovarian Cancers (Uninformative BRCA Test Results)

Breast/Ovarian Cancers (Testing)

Breast/Ovarian Cancers (Probability/Empiric Risks)

Breast/Ovarian Cancers (Risk Management)

Breast/Ovarian Cancers (Hormone Replacement Therapy)

Male Breast Cancers

Gastrointestinal Cancers (Lynch Related)

Gastrointestinal Cancers (Polyposis Syndromes)

Gastrointestinal Cancers (Non-Colorectal)

Gastrointestinal Cancers (Risk Management)

Genitourinary Cancer

Genodermatoses

Endocrine Neoplasias

Pediatric Cancers

ELSI-Ethical, Legal, Social Issues

 

Clinical Resources

Progeny/Pedigree Drawing Issues

 

Clinical Cancer Genetics Working Group

CCG Working Group Case Conferences

 

Comments/Suggestions

Suggestion/Comment Box

 

2015 Update Conference

2015 Clinical Cancer Genomics Update Conference

 
"From Evidence to Action: Next-Generation Approaches to Cancer Risk Assessment and Research"
City of Hope Division of Clinical Cancer Genetics (CCG), in collaboration with the University of Chicago, is excited to announce our 4th annual CME/CEU-accredited clinical cancer genetics and genomics update conference. The two-day conference will be held on Friday and Saturday, February 27 and 28, 2015, at City of Hope, Cooper Auditorium, in Duarte, CA.
 
 
 
 
Register earely and save!
 
        Conference Fee Structure*         
CCGCoP**
members:
Non-CCGCoP
members:
Physicians $200 $275
Genetic Counselors $100 $175
Nurses & other Health Professionals (NP, PA, SW) $100 $175
Industry $200 $275
Resident/Fellow $75 $125

*After 12/28/14, all fees will increase by $50.
**Affiliation with City of Hope Division of Clinical Cancer Genetics CCGCoP & CCGCRN
 
  • Prices include breakfast and lunch on Friday and Saturday, and a fun-filled networking dinner on Friday evening!
 
  • A block of rooms has been secured at a rate of $132 for single occupancy and $66 for shared at the Courtyard by Marriott, Monrovia, February 26 to 28, 2015. Don’t miss out on this great rate! (Conference attendees who want to extend their stay at the hotel may contact Karen Gadsby, at  626-531-8008.)
 
 
 
(group code pending)
 
To share accommodations with another conference attendee, contact Gloria Nunez at gnunez@coh.org no later than January 31, 2015.
 
 

Clinical Cancer Genetics Events Calendar

Clinical Cancer Genetics Events Calendar

Clinical Cancer Genetics
The City of Hope Division of Clinical Cancer Genetics is committed to being a national leader in the advancement of cancer genetics, screening and prevention, through innovative patient care, research and education.

Contact Us
  • 800-826-HOPE (4673)
  • For more information about the Cancer Screening & Prevention Program, call 626-256-8662, ext. 2.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
City of Hope Breakthroughs
Get the latest in City of Hope's research, treatment and news you can use on our blog, Breakthroughs.
 
 
NEWS & UPDATES
  • Ryan Chavira was a senior in high school when she began feeling sluggish, fatigued and, well, “down.” Trips to the doctor ended in “you’re fine” pronouncements; blood tests results showed nothing of real concern. But Chavira’s grandmother had passed away from ovarian cancer when she was in eig...
  • Brain tumors are exceptionally difficult to treat. They can be removed surgically, but individual cancer cells may have already spread elsewhere in the brain and can escape the effects of both radiation and chemotherapy. To prevent tumors from recurring, doctors need a way to find and stop those invasive cancer...
  • Breast cancer risk is personal; breast cancer risk assessment should be, too. To that end, City of Hope researchers have developed a starting point to help women (and their doctors) with a family history of the disease begin that risk assessment process. The result is an iPhone app, called BRISK, for Breast Can...
  • When it comes to breast cancer, women aren’t limited to getting screened and, if diagnosed, making appropriate treatment choices. They can also take a proactive stance in the fight against breast cancer by understanding key risk factors and practicing lifestyle habits that can help reduce their own breast...
  • Cancers of the blood and immune system are considered to be among the most difficult-to-treat cancers. A world leader in the treatment of blood cancers, City of Hope is now launching an institute specifically focused on treating people with lymphoma, leukemia and myeloma, as well as other serious blood and bone...
  • Genetics, genes, genome, genetic risk … Such terms are becoming increasingly familiar to even nonresearchers as studies and information about the human make-up become more extensive and more critical. At City of Hope, these words have long been part of our vocabulary. Researchers and physicians are studyi...
  • Mammograms are currently the best method to detect breast cancer early, when it’s easier to treat and before it’s big enough to feel or cause symptoms. But recent mammogram screening guidelines may have left some women confused about when to undergo annual testing. Here Lusi Tumyan, M.D., chief of t...
  • Although chemotherapy can be effective in treating cancer, it can also exact a heavy toll on a patient’s health. One impressive alternative researchers have found is in the form of a vaccine. A type of immunotherapy, one part of the vaccine primes the body to react strongly against a tumor; the second part dire...
  • The breast cancer statistic is attention-getting: One in eight women will be diagnosed with breast cancer during her lifetime. That doesn’t mean that, if you’re one of eight women at a dinner table, one of you is fated to have breast cancer (read more on that breast cancer statistic), but it does mean that the ...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. In his first post, ...
  • Advanced age tops the list among breast cancer risk factor for women. Not far behind is family history and genetics. Two City of Hope researchers delving deep into these issues recently received important grants to advance their studies. Arti Hurria, M.D., director of the Cancer and Aging Research Program, and ...
  • City of Hope is extending the reach of its lifesaving mission well beyond U.S. borders. To that end, three distinguished City of Hope leaders visited China earlier this year to lay the foundation for the institution’s new International Medicine Program. The program is part of City of Hope’s strategi...
  • A hallmark of cancer is that it doesn’t always limit itself to a primary location. It spreads. Breast cancer and lung cancer in particular are prone to spread, or metastasize, to the brain. Often the brain metastasis isn’t discovered until years after the initial diagnosis, just when patients were beginning to ...
  • Blueberries, cinnamon, baikal scullcap, grape seed extract (and grape skin extract), mushrooms, barberry, pomegranates … all contain compounds with the potential to treat, or prevent, cancer. Scientists at City of Hope have found tantalizing evidence of this potential and are determined to explore it to t...
  • Most women who are treated for breast cancer with a mastectomy do not choose to undergo reconstructive surgery. The reasons for this, according to a recent JAMA Surgery study, vary. Nearly half say they do not want any additional surgery, while nearly 34 percent say breast cancer reconstruction simply isn’t imp...